Tumor Lysis Syndrome in Patients with Hematological Malignancies

Tumor lysis syndrome is a metabolic complication that may follow the initiation of cancer therapy. It commonly occurs in hematological malignant patients particularly non-Hodgkin's lymphoma and acute leukemia due to chemotherapy or spontaneously. It is characterized by a biochemical abnormality...

Descripción completa

Detalles Bibliográficos
Autores principales: Belay, Yohannes, Yirdaw, Ketsela, Enawgaw, Bamlaku
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688348/
https://www.ncbi.nlm.nih.gov/pubmed/29230244
http://dx.doi.org/10.1155/2017/9684909

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688348/
https://www.ncbi.nlm.nih.gov/pubmed/29230244
http://dx.doi.org/10.1155/2017/9684909

Ejemplares similares